ISIN | CH0590186661 |
---|---|
Valor Number | 59018666 |
Bloomberg Global ID | SPISI SW |
Fund Name | UBS ETF (CH) - UBS SPI® ESG ETF CHF acc |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The sub-fund aims to replicate the price and return performance of the SPI® ESG Weighted gross of fees. This sub-fund invests its assets in stocks of companies that are included in the SPI® ESG Weighted and in stocks that are not in the SPI® ESG Weighted but for which notification of their inclusion in this index has been given, and in other investments permitted under the fund contract. In principle, the aim is to match the performance of the SPI ESG Weighted Total Return Index. |
Peculiarities |
Current Price * | 17.02 CHF | 09.10.2025 |
---|---|---|
Previous Price * | 17.05 CHF | 08.10.2025 |
52 Week High * | 17.05 CHF | 08.10.2025 |
52 Week Low * | 14.26 CHF | 09.04.2025 |
NAV * | 17.02 CHF | 09.10.2025 |
Issue Price * | 17.02 CHF | 09.10.2025 |
Redemption Price * | 17.02 CHF | 09.10.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,425,115,234 | |
Unit/Share Assets *** | 1,424,386,489 | |
Trading Information SIX |
YTD Performance | +12.20% |
31.12.2024 - 09.10.2025
31.12.2024 09.10.2025 |
---|---|---|
1 month | +2.40% |
09.09.2025 - 09.10.2025
09.09.2025 09.10.2025 |
3 months | +4.45% |
09.07.2025 - 09.10.2025
09.07.2025 09.10.2025 |
6 months | +19.38% |
09.04.2025 - 09.10.2025
09.04.2025 09.10.2025 |
1 year | +7.51% |
09.10.2024 - 09.10.2025
09.10.2024 09.10.2025 |
2 years | +22.38% |
12.10.2023 - 09.10.2025
12.10.2023 09.10.2025 |
3 years | +35.07% |
10.10.2022 - 09.10.2025
10.10.2022 09.10.2025 |
5 years | +34.33% |
23.02.2021 - 09.10.2025
23.02.2021 09.10.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 12.94% | |
---|---|---|
Roche Holding AG | 12.02% | |
Nestle SA | 8.85% | |
ABB Ltd | 6.81% | |
Zurich Insurance Group AG | 6.24% | |
Compagnie Financiere Richemont SA Class A | 5.37% | |
UBS Group AG Registered Shares | 4.55% | |
Swiss Re AG | 3.31% | |
Lonza Group Ltd | 2.09% | |
Swiss Life Holding AG | 2.07% | |
Last data update | 30.09.2025 |
TER | 0.12% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.13% |
Ongoing Charges *** | 0.12% |
SRRI ***
|
|
SRRI date *** | 30.09.2025 |